Clinical characteristics and natural history of patients with non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations treated with erlotinib or gefitinib Meeting Abstract


Authors: Riely, G. J.; Miller, V. A.; Pao, W.; Zakowski, M.; Ladanyi, M.; Heelan, R. T.; Kris, M. G.
Abstract Title: Clinical characteristics and natural history of patients with non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations treated with erlotinib or gefitinib
Meeting Title: 41st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 23
Issue: 16 Suppl.
Meeting Dates: 2005 May 13-17
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2005-06-01
Start Page: 641S
Language: English
ACCESSION: WOS:000230326604199
PROVIDER: wos
DOI: 10.1200/jco.2005.23.16_suppl.7085
Notes: --- - Meeting Abstract: 7085 - 41st Annual Meeting of the American-Society-of-Clinical-Oncology - MAY 13-17, 2005 - Orlando, FL - S - Part 1 - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. William Pao
    141 Pao
  2. Vincent Miller
    270 Miller
  3. Marc Ladanyi
    1326 Ladanyi
  4. Gregory J Riely
    599 Riely
  5. Maureen F Zakowski
    289 Zakowski
  6. Mark Kris
    869 Kris
  7. Robert T Heelan
    140 Heelan